1114561-85-1

1114561-85-1 structure

Name: BI 135585
Chemical Name: BI-135585
CAS Number: 1114561-85-1
Molecular Formula: C₂₈H₃₂N₂O₄
Molecular Weight: 460.565
Catalog: Research Areas Metabolic Disease
Create Date: 2018-06-13 15:19:57
Modify Date: 2024-01-09 21:13:33
BI-135585 is a potent, selective and orally active 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor with an IC50 of 13 nM. BI-135585 exhibits >1000-fold selectivity over other hydroxysteroid dehydrogenases. BI-135585 can be used for type 2 diabetes research[1][2].

Name	BI-135585
Synonyms	(6S)-6-(2-Hydroxy-2-methylpropyl)-3-{(1S)-1-[4-(1-methyl-2-oxo-1,2-dihydro-4-pyridinyl)phenyl]ethyl}-6-phenyl-1,3-oxazinan-2-one BI-135585 DA4HT8614K 2H-1,3-Oxazin-2-one, 3-[(1S)-1-[4-(1,2-dihydro-1-methyl-2-oxo-4-pyridinyl)phenyl]ethyl]tetrahydro-6-(2-hydroxy-2-methylpropyl)-6-phenyl-, (6S)-

Description	BI-135585 is a potent, selective and orally active 11β-hydroxysteroid dehydrogenase 1 (11β-HSD1) inhibitor with an IC50 of 13 nM. BI-135585 exhibits >1000-fold selectivity over other hydroxysteroid dehydrogenases. BI-135585 can be used for type 2 diabetes research[1][2].
Related Catalog	Signaling Pathways >> Others >> Others Research Areas >> Metabolic Disease
Target	IC50: 13 nM (11β-HSD1)[1]
In Vitro	BI-135585 binds in the substrate binding pocket of the active site of 11β-HSD1. Cellular activity of BI-135585 is examined by determining inhibition of 11β-HSD1 activity in human preadipocytes, the average IC50 is 1 nM[1]. In human adipose tissue ex vivo, BI-135585 inhibits the conversion of cortisone to cortisol with an average IC50 of 11 nM[1]. Abdominal subcutaneous and perirenal adipose tissue was harvested from one, male cynomolgus monkey. BI-135585 (20 hours) reduces enzyme activity in a dose-dependent manner with an IC50 of ~10 nM in perirenal adipose tissue and an IC50 of ~100 nM in abdominal subcutaneous adipose tissue[1].
In Vivo	BI-135585 (compound 11j; 1-3 mg/kg; po) inhibits 67% and 90% of enzyme activity respectively in perirenal adipose tissue in cynomolgus monkey[2].
References	[1]. Bradford S Hamilton, et al. Pharmacological characterization of the selective 11β-hydroxysteroid dehydrogenase 1 inhibitor, BI 135585, a clinical candidate for the treatment of type 2 diabetes. Eur J Pharmacol. 2015 Jan 5;746:50-5. [2]. Linghang Zhuang, et al. Discovery of BI 135585, an in vivo efficacious oxazinanone-based 11β hydroxysteroid dehydrogenase type 1 inhibitor. Bioorg Med Chem. 2017 Jul 15;25(14):3649-3657.

Density	1.2±0.1 g/cm3
Boiling Point	703.6±60.0 °C at 760 mmHg
Molecular Formula	C₂₈H₃₂N₂O₄
Molecular Weight	460.565
Flash Point	379.3±32.9 °C
Exact Mass	460.236206
LogP	3.69
Vapour Pressure	0.0±2.3 mmHg at 25°C
Index of Refraction	1.596

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

1114561-85-1	851658-10-1
64040-81-9	2750570-55-7
1453500-36-1	1423719-30-5
2166387-64-8	875145-22-5
1579514-06-9	958227-46-8
922082-65-3	86503-67-5
922108-65-4	922108-71-2
922108-77-8	922082-80-2
895473-32-2	84547-75-1
86824-68-2	922108-80-3